Literature DB >> 11960484

A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein.

Julie E Penzotti, Michelle L Lamb, Erik Evensen, Peter D J Grootenhuis.   

Abstract

P-glycoprotein (P-gp) functions as a drug efflux pump, mediating multidrug resistance and limiting the efficacy of many drugs. Clearly, identification of potential P-gp substrate liability early in the drug discovery process would be advantageous. We describe a multiple-pharmacophore model that can discriminate between substrates and nonsubstrates of P-gp with an accuracy of 63%. The application of this filter allows large virtual libraries to be screened efficiently for compounds less likely to be transported by P-gp.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960484     DOI: 10.1021/jm0255062

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  25 in total

Review 1.  Recent progress in the computational prediction of aqueous solubility and absorption.

Authors:  Stephen R Johnson; Weifan Zheng
Journal:  AAPS J       Date:  2006-02-03       Impact factor: 4.009

Review 2.  Pharmacophore-based discovery of ligands for drug transporters.

Authors:  Cheng Chang; Sean Ekins; Praveen Bahadduri; Peter W Swaan
Journal:  Adv Drug Deliv Rev       Date:  2006-09-26       Impact factor: 15.470

Review 3.  Molecular basis of the polyspecificity of P-glycoprotein (ABCB1): recent biochemical and structural studies.

Authors:  Eduardo E Chufan; Hong-May Sim; Suresh V Ambudkar
Journal:  Adv Cancer Res       Date:  2015-01-08       Impact factor: 6.242

4.  Isolated rafts from adriamycin-resistant P388 cells contain functional ATPases and provide an easy test system for P-glycoprotein-related activities.

Authors:  Karsten Bucher; Camille A Besse; Sarah W Kamau; Heidi Wunderli-Allenspach; Stefanie D Krämer
Journal:  Pharm Res       Date:  2005-03       Impact factor: 4.200

5.  Design, Synthesis, and Evaluation of Tetrasubstituted Pyridines as Potent 5-HT2C Receptor Agonists.

Authors:  Guy Rouquet; Dianna E Moore; Malcolm Spain; Daniel M Allwood; Claudio Battilocchio; David C Blakemore; Paul V Fish; Stephen Jenkinson; Alan S Jessiman; Steven V Ley; Gordon McMurray; R Ian Storer
Journal:  ACS Med Chem Lett       Date:  2015-01-20       Impact factor: 4.345

6.  De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.

Authors:  Hakan Gunaydin; Matthew M Weiss; Yaxiong Sun
Journal:  ACS Med Chem Lett       Date:  2012-11-06       Impact factor: 4.345

7.  Experimental and computational studies of epithelial transport of mefenamic acid ester prodrugs.

Authors:  Kamonthip Wiwattanawongsa; Vimon Tantishaiyakul; Luelak Lomlim; Yon Rojanasakul; Sirirat Pinsuwan; Sanae Keawnopparat
Journal:  Pharm Res       Date:  2005-05-17       Impact factor: 4.200

8.  Semantic similarity for automatic classification of chemical compounds.

Authors:  João D Ferreira; Francisco M Couto
Journal:  PLoS Comput Biol       Date:  2010-09-23       Impact factor: 4.475

9.  Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line.

Authors:  Hélène Chapy; Laura Goracci; Philippe Vayer; Yannick Parmentier; Pierre-Alain Carrupt; Xavier Declèves; Jean-Michel Scherrmann; Salvatore Cisternino; Gabriele Cruciani
Journal:  Br J Pharmacol       Date:  2015-10-13       Impact factor: 8.739

10.  Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs.

Authors:  Pär Matsson; Jenny M Pedersen; Ulf Norinder; Christel A S Bergström; Per Artursson
Journal:  Pharm Res       Date:  2009-05-07       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.